U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H32N2O2
Molecular Weight 392.5338
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXTROMORAMIDE

SMILES

C[C@H](CN1CCOCC1)C(C(=O)N2CCCC2)(C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=INUNXTSAACVKJS-OAQYLSRUSA-N
InChI=1S/C25H32N2O2/c1-21(20-26-16-18-29-19-17-26)25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3/t21-/m1/s1

HIDE SMILES / InChI
Molecular Formula C25H32N2O2
Molecular Weight 392.5338
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://books.google.ru/books?id=G7As-qawdzMC&printsec=frontcover&hl=ru#v=onepage&q&f=false | https://www.cbg-meb.nl/documenten/rapporten/2015/09/14/par-dextromoramide | https://medikamio.com/nl-nl/geneesmiddelen/palfium-tablet-5-mg/pil

Dextromoramide is a synthetic strong-acting opioid and full mu-opioid receptor agonist. Dextromoramide is a Schedule I drug illegal to possess. The current indication for Palfium® (dextromoramide) is severe acute or chronic pain requiring opioids, such as post-operative pain, and pain associated with bone fractures, malignancies and acute renal/biliary colic attacks in adults.

CNS Activity

Originator

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Agonist
2678
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Approved
8429
PALFIUM

Approved Use

Palfium® (dextromoramide) is a synthetic strong-acting opioid and full mu-opioid receptor agonist that has been registered in the Netherlands since 1974. The current indication is severe acute or chronic pain requiring opioids, such as post-operative pain, and pain associated with bone fractures, malignancies and acute renal/biliary colic attacks in adults.

Launch Date

1.26144004E11
PubMed

PubMed

TitleDatePubMed
Properties and analysis of dextromoramide and its dosage forms.
1961 Jan
Effect of methadone and dextromoramide on dopamine metabolism: comparison with haloperidol and amphetamine.
1975 Dec
Patents

Patents

GB822055
3

Sample Use Guides

In Vivo Use Guide
IM: 15 mg Intra Rectal: 20 mg PO: 0.071 to 0.285 mg/kg SC: 15 mg
Route of Administration: Other
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:11:31 UTC 2023
Edited
by admin
on Fri Dec 15 16:11:31 UTC 2023
Record UNII
9S4S6CIY83
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXTROMORAMIDE
INN   MART.   MI   WHO-DD  
INN  
Official Name English
(+)-4-(2-METHYL-4-OXO-3,3-DIPHENYL-4-(1-PYRROLIDINYL)BUTYL)MORPHOLINE
Systematic Name English
Dextromoramide [WHO-DD]
Common Name English
DEXTROMORAMIDE [MI]
Common Name English
4-(2-METHYL-4-OXO-3,3-DIPHENYL-4-(1-PYRROLIDINYL)BUTYL)MORPHOLINE
Systematic Name English
SKF-5137
Code English
LINFADOL
Brand Name English
dextromoramide [INN]
Common Name English
TROXILAN
Common Name English
ALCOID
Common Name English
RACEMORAMIDE, (S)-
Common Name English
PYRROLAMIDOL
Systematic Name English
JETRIUM
Common Name English
1-((3S)-3-METHYL-4-(4-MORPHOLINYL)-1-OXO-2,2-DIPHENYLBUTYL)PYRROLIDINE
Systematic Name English
1-BUTANONE, 3-METHYL-4-(4-MORPHOLINYL)-2,2-DIPHENYL-1-(1-PYRROLIDINYL)-, (3S)-
Systematic Name English
MCP-875
Code English
YETRIUM
Common Name English
NARCOLO
Brand Name English
R-875
Code English
DEXTROMORAMIDE [MART.]
Common Name English
MORAMIDE
Brand Name English
D-2,2-DIPHENYL-3-METHYL-4-MORPHOLINOBUTYRYLPYRROLIDINE
Common Name English
(+)-1-(3-METHYL-4-MORPHOLINO-2,2-DIPHENYLBUTYRYL)PYRROLIDINE
Systematic Name English
PALFADONNA
Common Name English
ACSCN-9613
Common Name English
IDS-ND-003
Code English
Classification Tree Code System Code
WHO-VATC QN02AC01
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
WHO-ATC N02AC01
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
DEA NO. 9613
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
NCI_THESAURUS C67413
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
Code System Code Type Description
CAS
357-56-2
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
NCI_THESAURUS
C87357
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
EPA CompTox
DTXSID8022909
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
MERCK INDEX
m4228
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY Merck Index
RXCUI
3290
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY RxNorm
DRUG CENTRAL
843
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
CHEBI
74274
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
FDA UNII
9S4S6CIY83
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
ECHA (EC/EINECS)
206-613-1
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
PUBCHEM
92943
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
MESH
D003916
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
SMS_ID
100000082898
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
EVMPD
SUB07052MIG
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
WIKIPEDIA
DEXTROMORAMIDE
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
INN
733
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
DRUG BANK
DB01529
Created by admin on Fri Dec 15 16:11:32 UTC 2023 , Edited by admin on Fri Dec 15 16:11:32 UTC 2023
PRIMARY
Related Record Type Details
Structure of RACEMORAMIDE
RACEMATE -> ENANTIOMER
Structure of DEXTROMORAMIDE TARTRATE
SALT/SOLVATE -> PARENT
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
Related Record Type Details
Structure of DEXTROMORAMIDE
ACTIVE MOIETY
(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine (A dextro-rotatory isomer of moramide). as per INCB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966